Go to content
UR Home

Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia

Bargou, Ralf C. ; Nagorsen, Dirk ; Zugmaier, Gerhard ; Benjamin, Jonathan E. ; Haddad, Vincent ; Wessels, Hendrik ; Stieglmaier, Julia ; Havelange, Violaine ; Horst, Heinz-August ; Brüggemann, Monika ; Topp, Max S. ; Diedrich, Helmut ; Faul, Christoph ; Graux, Carlos ; Reichle, Albrecht ; Bonifacio, Massimiliano ; Dombret, Hervé ; Gökbuget, Nicola


Approximately 30% to 50% of adults with acute lymphoblastic leukemia (ALL) in hematologic complete remission aftermultiagent therapy exhibit minimal residual disease (MRD) by reverse transcriptase-polymerase chain reaction or flow cytometry. MRD is the strongest predictor of relapse in ALL. In this open-label, single-arm study, adults with B-cell precursor ALL in hematologic complete remission ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons